Herold Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$432K Buy
6,262
+962
+18% +$66.4K 0.09% 201
2025
Q1
$368K Buy
5,300
+900
+20% +$62.5K 0.08% 202
2024
Q4
$378K Sell
4,400
-950
-18% -$81.7K 0.08% 203
2024
Q3
$637K Hold
5,350
0.14% 162
2024
Q2
$764K Sell
5,350
-600
-10% -$85.6K 0.18% 144
2024
Q1
$764K Buy
5,950
+950
+19% +$122K 0.18% 142
2023
Q4
$517K Buy
5,000
+2,600
+108% +$269K 0.14% 155
2023
Q3
$218K Buy
+2,400
New +$218K 0.07% 226